May 9, 2017 / 12:38 PM / 2 months ago

BRIEF-Aeglea Biotherapeutics Q1 revenue $1.0 mln vs $900,000

1 Min Read

May 9 (Reuters) - Aeglea Bio Therapeutics Inc

* Aeglea biotherapeutics provides corporate update and reports first quarter 2017 financial results

* Q1 revenue $1.0 million versus $900,000

* Q1 revenue view $1.7 million -- Thomson Reuters I/B/E/S

* Aeglea bio therapeutics inc - net loss totaled $6.2 million and $4.5 million for q1 of 2017 and 2016, respectively

* Aeglea bio therapeutics inc - at march 31, 2017, aeglea had available cash, cash equivalents and marketable securities of $57.9 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below